This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Industry-University Cooperation Foundation Hanyang University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Jae-Ung Lee: Innovator in Gene Correction Technology
Introduction
Jae-Ung Lee is a prominent inventor based in Siheung, South Korea. He has made significant contributions to the field of gene correction technology, particularly through his work with CRISPR-Cas systems. His innovative approach has the potential to revolutionize genetic engineering and therapeutic applications.
Latest Patents
Jae-Ung Lee holds a patent for a "CRISPR-Cas-Based Composition for Gene Correction." This patent represents a critical advancement in the ability to edit genes with precision and efficiency. His work in this area is paving the way for new treatments for genetic disorders.
Career Highlights
Lee is affiliated with the Industry-University Cooperation Foundation at Hanyang University. His role at this institution allows him to bridge the gap between academic research and practical applications in the industry. His dedication to advancing gene correction technology is evident in his research and patent contributions.
Collaborations
Throughout his career, Jae-Ung Lee has collaborated with notable colleagues, including Je-Min Choi and Ja-Hyun Koo. These partnerships enhance the scope and impact of his research, fostering innovation in the field of genetic engineering.
Conclusion
Jae-Ung Lee is a key figure in the realm of gene correction technology, with a focus on CRISPR-Cas systems. His contributions through patents and collaborations highlight his commitment to advancing scientific knowledge and practical applications in genetics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile